Skip to main content
. 2008 Sep 23;93(12):4767–4773. doi: 10.1210/jc.2007-2614

Table 2.

Serum sex hormones, IGF-I, and IGFBP-3

Placebo
DHEA
Baseline 12 months Baseline 12 months P valuea
Women
 DHEAS (μmol/liter) 1.2 (0.7) 1.1 (0.7) 1.5 (1.0) 7.1 (5.0) <0.001
 Total testosterone (nmol/liter)b 1.0 (0.3) 0.9 (0.4) 1.2 (0.8) 2.2 (1.3) <0.001
 SHBG (nmol/liter) 182.5 (83.7) 183.2 (88.4) 149.1 (67.1) 121.9 (61.7) 0.005
 FTI (pmol/liter)c 7.0 (4.0) 8.0 (4.0) 9.0 (6.0) 25.0 (15.0) <0.001
 E2 (pmol/liter) 116.7 (43.0) 118.9 (45.9) 113.8 (30.8) 183.2 (71.6) <0.001
 E1 (pmol/liter) 94.7 (43.3) 94.0 (37.4) 105.0 (42.9) 187.2 (99.1) <0.001
 FEI (pmol/liter)c 2.2 (1.2) 2.3 (1.0) 2.3 (1.4) 5.1 (2.7) <0.001
 IGF-I (nmol/liter) 14.8 (6.6) 13.8 (5.2) 14.0 (5.3) 17.2 (6.3) 0.028
 IGFBP-3 (nmol/liter) 114.8 (31.2) 117.6 (34.3) 119.7 (36.4) 118.3 (36.4) 0.941
Men
 DHEAS (μmol/liter) 1.7 (0.7) 2.9 (0.6) 1.7 (0.7) 8.8 (4.9) <0.001
 Total testosterone (nmol/liter) 13.9 (4.6) 14.1 (4.7) 13.6 (3.9) 12.4 (3.2) 0.114
 SHBG (nmol/liter) 126.0 (64.3) 126.7 (66.5) 107.8 (41.4) 96.7 (39.3) 0.037
 FTI (pmol/liter) 156.0 (48.0) 161.0 (42.0) 169.0 (52.0) 172.0 (56.0) 0.417
 E2 (pmol/liter) 171.4 (45.2) 175.8 (34.1) 174.7 (42.6) 235.3 (83.3) 0.001
 E1(pmol/liter) 127.2 (58.1) 128.0 (53.3) 119.5 (53.6) 176.8 (102.1) 0.022
 FEI (pmol/liter) 5.9 (1.6) 6.0 (1.4) 6.6 (1.4) 8.7 (2.9) 0.001
 IGF-I (nmol/liter) 15.5 (6.5) 14.1 (5.6) 15.5 (5.6) 16.0 (6.1) 0.207
 IGFBP-3 (nmol/liter) 98.7 (34.0) 96.2 (36.0) 104.6 (34.3) 104.0 (36.0) 0.413

Values are mean (sd). 

a

Between-group comparisons of 12-month values; differences between groups at baseline were not significant (P > 0.05). 

b

Total testosterone was below the limit of detection (0.59 nmol/liter) in 26 women (11 placebo, 14 DHEA) at baseline and 16 women (11 placebo, five DHEA) at 12 months. 

c

Cases with undetectable total testosterone concentrations were assumed to be 0.58 nmol/liter for the calculations of the FTI and FEI.